CE-Ventures invests in $55mn Series A to advance Noonan syndrome therapies
Funding will accelerate development of first-in-class small-molecule drugs for a condition with no approved targeted treatments The post CE-Ventures invests in $55mn Series A to advance Noonan syndrome therapies appeared first on Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More.
Funding will accelerate development of first-in-class small-molecule drugs for a condition with no approved targeted treatments
The post CE-Ventures invests in $55mn Series A to advance Noonan syndrome therapies appeared first on Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More.
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
